	US 12,439,952 B2
	Moist oral compositions
Darrell Eugene Holton, Jr., Clemmons, NC (US); Dwayne William Beeson, Kernersville, NC (US); Andinet Amare Gessesse, Malmo (SE); Philip Richard Hunt, Malmo (SE); Ronald K. Hutchens, East Bend, NC (US); Christopher Keller, Advance, NC (US); Thomas H. Poole, Winston-Salem, NC (US); and Frank Kelley St. Charles, Bowling Green, KY (US)
Assigned to Nicoventures Trading Limited, London (GB)
Filed by NICOVENTURES TRADING LIMITED, London (GB)
Filed on Jun. 9, 2022, as Appl. No. 17/836,854.
Application 17/836,854 is a continuation of application No. PCT/IB2020/061416, filed on Dec. 3, 2020.
Application 17/836,854 is a continuation of application No. 16/707,351, filed on Dec. 9, 2019, granted, now 11,617,744.
Prior Publication US 2022/0295868 A1, Sep. 22, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/465 (2006.01); A24B 13/00 (2006.01); A24B 15/16 (2020.01); A24B 15/30 (2006.01); A24B 15/38 (2006.01); A24B 15/40 (2006.01); A61K 9/00 (2006.01); A61K 36/185 (2006.01); A61K 47/40 (2006.01)

CPC A24B 15/385 (2013.01) [A24B 13/00 (2013.01); A24B 15/303 (2013.01); A24B 15/308 (2013.01)]

20 Claims

1. An oral composition comprising:

at least one active agent;

at least one filler component selected from the group consisting of microcrystalline cellulose, mannitol, and combinations thereof;

at least one humectant selected from the group consisting of glycerin, propylene glycol, and combinations thereof; and

water in an amount of about 15% to about 30% by weight based on the total weight of the oral composition.